SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001798749-23-000042
Filing Date
2023-06-08
Accepted
2023-06-08 16:30:34
Documents
12
Period of Report
2023-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230606x8k.htm   iXBRL 8-K 52300
  Complete submission text file 0001798749-23-000042.txt   176820

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20230606.xsd EX-101.SCH 3122
3 EX-101.LAB tmb-20230606_lab.xml EX-101.LAB 16576
4 EX-101.PRE tmb-20230606_pre.xml EX-101.PRE 10778
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230606x8k_htm.xml XML 4990
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 231002332
SIC: 2834 Pharmaceutical Preparations